Precisely, animal models of Alzheimer’s disease (AD) illustrate that PA is an effective way to positively modify pathophysiological processes, including β-amyloid (Aβ) burden, tau phosphorylation, and neuronal loss [18]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.